newsfilter
← Latest News
FDA Approved Drugs·

Approval of Neulasta, Bla #125031

Approval Date: 08/04/2026; Drug Name: Neulasta, Bla #125031; Active Ingredients: PEGFILGRASTIM; Company: Amgen; Submission Status: Approval; Application Number: 125031

Company
AMGEN
Keywords
AMGEN